Cargando…
Digoxin Use Is Associated With Reduced Interstage Mortality in Patients With No History of Arrhythmia After Stage I Palliation for Single Ventricle Heart Disease
BACKGROUND: Interstage mortality (IM) remains significant after stage 1 palliation (S1P) for single‐ventricle heart disease (SVD), with many deaths sudden and unexpected. We sought to determine whether digoxin use post‐S1P is associated with reduced IM, utilizing the multicenter database of the Nati...
Autores principales: | Brown, David W., Mangeot, Colleen, Anderson, Jeffrey B., Peterson, Laura E., King, Eileen C., Lihn, Stacey L., Neish, Steven R., Fleishman, Craig, Phelps, Christina, Hanke, Samuel, Beekman, Robert H., Lannon, Carole M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859359/ https://www.ncbi.nlm.nih.gov/pubmed/26755552 http://dx.doi.org/10.1161/JAHA.115.002376 |
Ejemplares similares
-
Temporary bronchial stenting for airway compression in the interstage palliation of functional single ventricle
por: Barnes, Jason Hawes, et al.
Publicado: (2019) -
Association of Digoxin With Interstage Mortality: Results From the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Use Dataset
por: Oster, Matthew E., et al.
Publicado: (2016) -
Improving Outcomes for Infants with Single Ventricle Physiology through Standardized Feeding during the Interstage
por: Weston, Cindy, et al.
Publicado: (2016) -
Association of Digoxin With Preserved Echocardiographic Indices in the Interstage Period: A Possible Mechanism to Explain Improved Survival?
por: Batsis, Maria, et al.
Publicado: (2021) -
Initial Experience with Telemedicine for Interstage Monitoring in Infants with Palliated Congenital Heart Disease
por: Stagg, Alyson, et al.
Publicado: (2022)